Psychological impact of endometrial monitoring in tamoxifen-treated postmenopausal breast cancer patients

被引:1
|
作者
Demyttenaere, K
Gheldof, M
Enzlin, P
Timmerman, D
Deprest, J
Bourne, T
Vergote, I
机构
[1] Catholic Univ Louvain, Dept Psychiat, Hosp Gasthuisberg, B-3000 Louvain, Belgium
[2] Catholic Univ Louvain, Dept Obstet & Gynecol, Hosp Gasthuisberg, B-3000 Louvain, Belgium
[3] St George Hosp, Sch Med, Acad Dept Obstet & Gynaecol, London, England
来源
关键词
breast cancer; endometrial surveillance; psychological impact; compliance;
D O I
10.3109/01674820009085592
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
In view of the higher incidence of endometrial pathology In tamoxifen-treated; breast cancer patients, it has been recommended that endometrial surveillance be performed on these women by means of transvaginal sonography. Our study investigated how breast cancer patients experience the endometrial surveillance and which personality factors influence this experience.: We also: studied compliance with the recommended examination. Fifty-three consecutive asymptomatic postmenopausal breast cancer patients who had taken tamoxifen for at least 6 months were included. Our results show that 23 % of the women felt very anxious just before the examination. One woman in five evaluated the procedure as annoying, unpleasant, invasive and awkward, but only 3 % found it really unacceptable. Difficulties in coping with mastectomy as well as anxiety negatively affected the experience of the examination. One in six women were doubtful about their ability to comply with such an examination in the future Women who have difficulties in coming to terms with the mastectomy, anxious, women, and women with a low tolerance, towards common medical procedures are at especial risk of becoming dropouts. Suggestions are made for developing strategies that might improve these women's compliance.
引用
收藏
页码:225 / 233
页数:9
相关论文
共 50 条
  • [41] A multimarker model to predict outcome in tamoxifen-treated breast cancer patients
    Linke, SP
    Bremer, TM
    Herold, CD
    Sauter, G
    Diamond, C
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1175 - 1183
  • [43] Different coexisting endometrial histological features in asymptomatic postmenopausal breast cancer patients treated with tamoxifen
    Cohen, I
    Altaras, MM
    Shapira, J
    Tepper, R
    Cordoba, M
    Figer, A
    Zalel, Y
    Dror, Y
    Beyth, Y
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1997, 43 (01) : 60 - 63
  • [44] Doppler flow evaluation of pathological endometrial conditions in postmenopausal breast cancer patients treated with tamoxifen
    Tepper, Ronnie
    Cohen, Ilan
    Altaras, Marco
    Shapira, Jeremiah
    Cordoba, Mario
    Dror, Yiagel
    Beyth, Toram
    Journal of Ultrasound in Medicine, 1994, (05)
  • [45] Ovarian cysts in tamoxifen-treated women with breast cancer
    Inal, MM
    Incebiyik, A
    Sanci, M
    Yildirim, Y
    Polat, M
    Pilanci, B
    Nayki, C
    Camuzcuoglu, H
    EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 120 (01): : 104 - 106
  • [46] Significance of secondary ultrasonographic endometrial thickening in postmenopausal tamoxifen-treated women - Author reply
    Cohen, I
    Azaria, R
    Shapira, J
    Yigael, D
    Tepper, R
    CANCER, 2003, 98 (02) : 432 - 433
  • [47] Tamoxifen-treated breast cancer patients and the rate of cardiovascular events in a Danish cohort
    Hernandez, R. K.
    Sorensen, H. T.
    Lash, T. L.
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2008, 167 (11) : S119 - S119
  • [50] Cytologic endometrial surveillance in tamoxifen-treated women
    Labi, FL
    Meggiorini, ML
    Nusiner, MP
    Di Lillo, A
    Cascialli, SL
    Ogbonna, NO
    Cosmi, EV
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2002, 23 (06) : 537 - 539